Redeye Feed

2025-07-11 11:59:00 Alligator Bioscience Q2 2025 - Progress with HLX22 and Mitazalimab

2025-07-11 11:57:00 Nanologica Q2 2025 - Low near-term visibility but encouraging long-term case

2025-07-11 11:56:00 Arise - Updated estimates ahead of the Q2 report

2025-07-11 11:55:00 Carasent - Solid ARR despite lowered target

2025-07-10 11:11:00 Litium - ARR you ready for this?

2025-07-10 11:10:00 CTEK - Fine-tuned estimates ahead of the Q2 report

2025-07-10 11:09:00 Transtema Q2 Preview - Breakthrough deal in power and lowered short-term margin assumptions

2025-07-08 09:14:00 Vertiseit - First Roll-up-like acquisition targeting key customer relations

2025-07-08 09:12:00 Carasent prel. Q2 - Soft Q2 causing revised 2025 targets – largely aligning with our unrevised forecasts

2025-07-07 09:38:00 Hexatronic prel. Q2 2025 - Weak Fiber Solutions hurting

2025-06-27 18:18:00 OssDsign - First PROPEL data looks strong

2025-06-27 08:45:00 Polygiene - Retake – Scalability in Focus

2025-06-19 13:44:00 Biovica - Adding cash and increased market distribution

2025-06-19 08:23:00 Eniro Group - Reshaped and recharged – Eniro’s next chapter

2025-06-17 09:35:00 Redeye Initiates Coverage of Isofol Medical

2025-06-16 11:59:00 Hexatronic - Q2 2025 Preview – FX hurting

2025-06-11 11:15:00 Redeye Initiates Coverage of Xplora Technologies

2025-06-11 11:12:00 Annexin Q1 - Positioned for dealmaking

2025-06-09 14:12:00 Systemair - Firm margins despite soft top-line

2025-06-04 08:45:00 Integrum Q4 - Warming up for coming quarters

2025-06-04 08:44:00 Genovis Q1 2025 - Interesting outlook but limited near-term visibility

2025-06-04 08:43:00 Litium - Same code, sharper ambition

2025-06-04 08:42:00 BioArctic - BMS deal a promising start for BBB-platform, Leqembi ramp up slower than expected

2025-05-30 13:19:00 AcouSort Q1 - In line with estimates

2025-05-30 11:39:00 Saniona Q1 - More deals on the menu

2025-05-30 11:37:00 Sprint Bioscience - Increased pressure ahead of the next sprint baton-exchange

2025-05-30 11:36:00 Verve Group - Increased market uncertainty

2025-05-30 11:35:00 MindArk - Continued investing yet to shine through to sales

2025-05-28 10:59:00 FluoGuide Q1 2025 - Phase II HNC readout around the corner

2025-05-28 10:20:00 Elicera Therapeutics Q1 - Positive pattern emerging in CARMA trial

2025-05-28 10:19:00 SynAct Pharma Q1 2025 - New Phase II Study in Dengue Fever

2025-05-27 08:39:00 Kancera Q1 - Continued efforts with Recardio

2025-05-27 08:38:00 Embracer - Soft near-term outlook, solid longer-term pipeline

2025-05-27 08:36:00 Lipigon Q1 2025 - 64.5% Subscription Rate in the Rights Issue

2025-05-26 20:50:00 Vertiseit - Summit Season

2025-05-26 20:49:00 Jumpgate - All eyes to the upcoming quarters

2025-05-26 11:32:00 Better Collective - Improved visibility

2025-05-26 11:31:00 CTEK - A CMD that underpins the new financial targets

2025-05-22 13:01:00 Camurus Q1 2025 - Buvidal On Target, Brixadi Flat

2025-05-22 12:59:00 Neola Medical Q1 - Clinical progress on track

2025-05-22 12:58:00 Flexion Mobile - Solid report with no surprises

2025-05-21 11:02:00 Oncopeptides Q1 2025 - Strong Q/Q Growth with Japan the Next Catalyst

2025-05-21 10:59:00 Lagercrantz - Twin engines working in tandem

2025-05-20 22:30:00 Cinclus Pharma Q1 - Focus on upcoming pivotal study

2025-05-20 22:29:00 Scibase Q1 - Laying the groundwork for US expansion

2025-05-19 13:21:00 Ascelia Pharma update - Funded for near-term triggers ahead

2025-05-19 13:19:00 CLS Q1 - A solid quarter largely in line with our expectations

2025-05-19 13:18:00 Paxman Q1 - Softer quarter than expected, but CIPN adds long-term value

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden